Company Filing History:
Years Active: 2017
Title: Catherine E Safran: Innovator in Injectable Delivery Systems
Introduction
Catherine E Safran is a prominent inventor based in Bear, Delaware. She has made significant contributions to the field of biomedical engineering, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing therapeutic outcomes through advanced delivery methods.
Latest Patents
Catherine holds a patent for an "Injectable delivery system for heparan-binding growth factors." This invention outlines a method for enhancing chondrogenesis in subjects in need. The method involves administering an effective amount of a pharmaceutical composition that includes a growth factor bound to hyaluronic acid (HA)-based hydrogel particles (HGPs). These HGPs are conjugated with a heparan sulfate proteoglycan (HSPG), providing a novel approach to delivering growth factors effectively.
Career Highlights
Catherine is affiliated with the University of Delaware, where she continues her research and development efforts. Her work has garnered attention for its potential applications in regenerative medicine and tissue engineering. With 1 patent to her name, she exemplifies the innovative spirit of modern inventors.
Collaborations
Catherine has collaborated with notable colleagues, including Mary C Farach-Carson and Xinqiao Jia. These partnerships have enriched her research and expanded the impact of her inventions in the scientific community.
Conclusion
Catherine E Safran is a trailblazer in the field of injectable delivery systems, with her innovative patent paving the way for advancements in medical treatments. Her contributions reflect the importance of research and collaboration in driving innovation forward.